Treatment of Left Heart Insufficiency in an Operative Setting of Cardiac Surgery
Conditions
Keywords
levosimendan, renal effects, cardiac surgery, left heart insufficiency
Brief summary
Recent experimental and clinical data suggest a benefit of levosimendan on the kidney function. Therefore, this retrospective, single center, matched-pairs analysis aimed to investigate whether administration of levosimendan was associated with improved renal function in cardiac surgery patients.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients undergoing cardiac surgery (OPS 5-35 bis 5-37) between 2007 and 2011 followed by postoperative observation on an ICU of the anaesthesiology department of the Charité hospital
Exclusion criteria
* Patients younger 18 * Preexisting renal insufficiency
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of plasma creatinine (Difference in renal function) | last available value pre-op (baseline), first available value on post-op day 1, 2, 3 and 4 | Only in patients not requiring renal replacement therapy |
| Change of urine output after surgery (difference in renal function) | post-op day 1, 2, 3, 4 | Only in patients not requiring renal replacement therapy |
| Cumulative incidence and duration of hemodialysis (Difference in renal function) | last day of hospital stay | — |
Secondary
| Measure | Time frame |
|---|---|
| Cumulative Length of stay (hospital and ICU) | last day of hospital stay |
| In-hospital mortality | last day of hospital stay |
Countries
Germany